AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
Latest pharma news updates

To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has included the development of novel drug delivery approaches to enhance anti-tumor immune response and incorporating unique 3D screening methodologies for selecting novel therapeutic molecules.

"Our oncology collaboration with the University of Chicago enables us to combine our expertise in understanding the underlying biology in key areas of interest, such as immuno-oncology, oncogenic pathways, and biomarkers of drug sensitivity or disease," said Steve Davidsen, Vice President, Oncology Discovery Research at AbbVie. "This effort drives towards a common goal of accelerating discovery efforts and delivering novel therapies to people living with cancer." 

Continuing the intent of the initial research collaboration, the extension of the collaboration is designed to further accelerate and advance medical research in oncology at both organizations.

"Our ambition is that the clinical and translational collaboration between AbbVie and the University of Chicago continues to impact public health positively," said Kunle Odunsi, M.D., Ph.D., AbbVie Foundation Director, University of Chicago Medicine Comprehensive Cancer Center. "The collaboration has created valuable opportunities for scientific exchange and the development of clinical trials for cancer research."

Under the agreement, the organizations will continue working together to advance research in several areas, focusing on oncology, and AbbVie gains an option for an exclusive license to certain University of Chicago discoveries made as part of the collaboration.

"We look forward to more discoveries together in the years to come," said Juan de Pablo, University of Chicago Vice President for National Laboratories, Science Strategy, Innovation, and Global Initiatives. "The extension of our agreement will continue to provide faculty and students with opportunities to work with colleagues at a global biopharmaceutical leader and translate their findings from the lab into the real world. It will enable the kind of preclinical research that is needed to help lay the foundations for better approaches and treatments with the goal to ultimately improve quality of life for patients."

Tags : #Abbvie #UniversityofChicago #Oncology #SteveDavidsen

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

No health, gender and economic justice without ending wars, invasions and genocidesJuly 19, 2025
Venus Remedies Secures WHO GDP Endorsement for Best-in-Class Pharma LogisticsJuly 18, 2025
Single Surgeon Performs 17 Joint Replacements in 8 Hours at CARE Banjara, Setting New Benchmark in Orthopedic ExcellenceJuly 17, 2025
Sterling Hospitals Rajkot Achieves a Medical Milestone: Successfully Treats Rare and Life-Threatening Heart Condition RSOV Without Open Heart SurgeryJuly 17, 2025
Vidyadhan Alumni and Students Successfully Host Third Annual Blood Donation DriveJuly 17, 2025
HOSMAC Signs MoU with Gulf Medical University as Industry Partner to Strengthen Healthcare Education and CollaborationJuly 17, 2025
Why Teens Can’t Wake Up Early: The Hidden Problem of School TimingsJuly 17, 2025
Code Blue to Code Smart: How AI is Reshaping ICU Risk StratificationJuly 17, 2025
TERN Group Launches Its 7th Training Centre - and First Dedicated to Japanese Language & Careers - in GuwahatiJuly 16, 2025
Sri Sathya Sai Heart Hospital Ahmedabad and Rajkot signed an MOU with Gujarat Health Department for free heart surgery for needy children and adults July 16, 2025
No health without rights, says Shobha Shukla SDG-3 Lead Discussant at UN meetJuly 15, 2025
30 Minutes To Freedom, Robotic Surgery Ends 89-YO’s Swallowing NightmareJuly 15, 2025
Himalaya Wellness Champions Bhringaraja in New Anti-Hair Fall Campaign with a Tale of FriendshipJuly 15, 2025
ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment July 15, 2025
Reforming global financial architecture is critical for gender equality and right to healthJuly 14, 2025
Francesco Arezzo takes office as president of Rotary InternationalJuly 14, 2025
CBM India Highlights Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA 19th Annual ConferenceJuly 14, 2025
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy’July 14, 2025
NMC Notifies Medical Institutions (Qualifications of Faculty) Regulations, 2025 to Expand Medical Education Capacity and Strengthen Faculty Availability July 14, 2025
India’s Roads, India’s Pain: Healing Beyond the HospitalJuly 14, 2025